The axis of integrin α11-FAK-GLI-1/EZH2, formed in drug-resistant breast cancer cells, represents a shared positive feedback loop in both TAMR and ADR cells, which sustains the overexpression of EZH2 and ITGA11, thereby inducing drug resistance and CSC expansion (Fig. 8). Here, EZH2 is linked to breast carcinoma.